We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App





Pfizer Could Seek FDA Emergency Use Authorization for COVID-19 Vaccine in October

By HospiMedica International staff writers
Posted on 07 Sep 2020
Print article
Illustration
Illustration
Pfizer Inc. (New York, NY, USA) should know by October if its COVID-19 vaccine candidate currently under trial works, based on which it plans to immediately seek Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA).

Speaking at an online press briefing organized by the International Federation of Pharmaceutical Manufacturers and Associations, Pfizer’s Chief Executive Albert Bourla said that the company would submit the candidate for approval immediately if the vaccine, developed in partnership with Biopharmaceutical New Technologies (BioNTech Mainz, Germany), proved to be safe and effective in the studies.

Pfizer’s recruitment for the trial is currently progressing ahead of its original plans and 23,000 patients have been enrolled until now. According to Bourla, the availability of the vaccine’s study data would be determined by the speed at which its scientists work and the severity of COVID-19 infection at its study locations in the US, Argentina and Brazil.

"Based on our calculations, we are expecting that to be in October," said Bourla.

Related Links:
Pfizer Inc.
Biopharmaceutical New Technologies


BMP Whole Blood Analyzer: GEM Premier ChemSTAT
New
Gold Supplier
Multiplexed Molecular POC Diagnostic System
FLASH Dx
New
Oxygen Hood
Oxygen Hood
New
Virtual Report Viewing System
CliniNet

Print article

Channels

AI

view channel
Image: EchoGo Heart Failure is the first and only AI-enabled HFpEF detection platform for echocardiography (Photo courtesy of Ultromics)

AI Solution for Echocardiography to Revolutionize Diagnosis of Heart Failure with Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) is a type of heart failure often associated with co-morbidities and tends to be caused by increased pressure within the chambers of the heart.... Read more

Critical Care

view channel
Image: Lodestar DX provides lab-accurate test results in 30 minutes (Photo courtesy of Llusern Scientific)

Portable UTI Molecular Diagnostic Platform Provides Accurate Test Results in 40 Minutes

Despite being one of the most common types of infection Urinary Tract Infections (UTIs) are a comparatively neglected area of medicine. There are no highly accurate diagnostic tools available for point-of-care... Read more

Surgical Techniques

view channel
Image: ActivSight Intelligent Light has received CE Mark approval (Photo courtesy of Activ Surgical)

Enhanced Imaging System to Become a Game-Changer in the OR by Revolutionizing Surgical Vision

Critical structure identification and tissue perfusion assessment are essential for patients to have the best possible chance of healing well without facing life-threatening or costly complications.... Read more

Patient Care

view channel
Image: Automated cleaning system allows endoscopes to be cleaned direct from clinic (Photo courtesy of Aston University)

World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance

Endoscopes are long, thin tubes with a light and camera at one end. Due to the sensitivity of the materials and electronics they cannot be sterilized in an autoclave (a machine that uses steam under pressure),... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The global multiparameter patient monitoring systems market is expected to surpass USD 15 billion by 2028 (Photo courtesy of Unsplash)

Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses

Multi-parameter patient monitoring equipment is used to assess the vital signs of patients who are suffering from a serious illness. These devices are meant to give the number of data sets on one screen... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.